This site is intended for healthcare professionals

Reversal of NOACs part 2: direct factor IIa inhibitors

Join the panel as they discuss the recent approval, and use of, specific factor IIa reversal agents.

Please note, the slides available for download represent a guide to aid discussion; they are not exhaustive and do not necessarily reflect the opinion of the speakers or of